Influenza Illness and Partial Vaccination in the First Two Years of Life.

fever hospitalization human influenza vaccination vaccine effectiveness

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
20 Jun 2021
Historique:
received: 25 05 2021
revised: 15 06 2021
accepted: 16 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 3 7 2021
Statut: epublish

Résumé

More information about influenza in low- and middle-income countries could guide the establishment of pediatric influenza vaccine programs. This study (1) characterizes the burden of influenza in infants, and (2) compares signs and symptoms by prior influenza vaccination or influenza illness. Newborns from Managua, Nicaragua, were followed for two years. Data came from primary medical appointments, PCR testing, and parents' daily symptom diaries. Logistic regression models estimated associations between preceding vaccination or illness and influenza incidence. Linear models compared duration of illness by prior vaccination or influenza illness. Among 833 infants, 31% had PCR-positive influenza, and 28% were vaccinated against influenza. Four (<0.5%) were fully vaccinated. Overall, influenza incidence was 21.0 (95% confidence interval (CI): 18.8, 23.2) per 100 person-years. Incidence was lower among those with prior influenza compared with those without preceding illness or vaccination (OR: 0.64, 95% CI: 0.44, 0.94). Partially vaccinated children had 1 day less fever than those without prior illness or vaccination (

Identifiants

pubmed: 34203000
pii: vaccines9060676
doi: 10.3390/vaccines9060676
pmc: PMC8235291
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : CDC HHS
ID : 1U01GH000028-04
Pays : United States
Organisme : NIAID NIH HHS
ID : HHSN272201400006C
Pays : United States

Références

N Engl J Med. 2013 Dec 26;369(26):2481-91
pubmed: 24328444
Influenza Other Respir Viruses. 2018 Jan;12(1):38-45
pubmed: 29197152
Lancet. 2011 Dec 3;378(9807):1917-30
pubmed: 22078723
Clin Infect Dis. 2014 Dec 1;59(11):1519-24
pubmed: 25139969
BMC Infect Dis. 2015 Oct 24;15:447
pubmed: 26497393
Acta Paediatr. 2010 Oct;99(10):1517-21
pubmed: 20456265
JAMA. 2010 Sep 8;304(10):1091-8
pubmed: 20823435
Expert Rev Vaccines. 2013 Sep;12(9):1085-94
pubmed: 24024871
Pediatr Infect Dis J. 2016 Feb;35(2):152-6
pubmed: 26421805
Lancet Infect Dis. 2010 Aug;10(8):521-6
pubmed: 20620116
Lancet Glob Health. 2020 Apr;8(4):e497-e510
pubmed: 32087815
Influenza Other Respir Viruses. 2018 Jan;12(1):30-37
pubmed: 29243402
Clin Infect Dis. 2017 Oct 16;65(9):1532-1541
pubmed: 29020267
Lancet. 2018 Mar 31;391(10127):1285-1300
pubmed: 29248255
PLoS One. 2013 Aug 14;8(8):e70867
pubmed: 23967126
Vaccine X. 2019 Nov 02;3:100047
pubmed: 31867577
Vaccine. 2020 Jun 2;38(27):4325-4335
pubmed: 32387013
Vaccine. 2018 Sep 5;36(37):5536-5543
pubmed: 30076103
Clin Infect Dis. 2010 Jun 1;50(11):1462-7
pubmed: 20420502
Lancet Glob Health. 2019 Jul;7(7):e827-e828
pubmed: 31200881
Influenza Other Respir Viruses. 2016 Jul;10(4):340-5
pubmed: 26946216
Vaccine. 2019 Jan 14;37(3):464-472
pubmed: 30502070
Blood. 2011 May 12;117(19):5050-6
pubmed: 21372154
Vaccine. 2019 May 21;37(23):2982-2989
pubmed: 31027928
Lancet Infect Dis. 2012 Jan;12(1):36-44
pubmed: 22032844
JAMA. 2020 Sep 15;324(11):1029-1030
pubmed: 32930764
BMC Infect Dis. 2015 Nov 09;15:504
pubmed: 26553094
MMWR Recomm Rep. 2018 Aug 24;67(3):1-20
pubmed: 30141464
Hum Vaccin Immunother. 2016 Aug 2;12(8):2206-2214
pubmed: 27196006
Clin Infect Dis. 2016 Dec 15;63(12):1564-1573
pubmed: 27702768
Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S13-20
pubmed: 21333967
J Infect Dis. 2016 May 15;213(10):1546-56
pubmed: 26743842

Auteurs

Abram L Wagner (AL)

Department of Epidemiology, School of Public Health, University of Michigan, 1415 Washington Heights, Ann Arbor, MI 48109, USA.

Lionel Gresh (L)

Sustainable Sciences Institute, Managua 14007, Nicaragua.

Nery Sanchez (N)

Sustainable Sciences Institute, Managua 14007, Nicaragua.
Centro de Salud Sócrates Flores Vivas, Ministry of Health, Managua 12014, Nicaragua.

Guillermina Kuan (G)

Sustainable Sciences Institute, Managua 14007, Nicaragua.
Centro de Salud Sócrates Flores Vivas, Ministry of Health, Managua 12014, Nicaragua.

John Kubale (J)

Department of Epidemiology, School of Public Health, University of Michigan, 1415 Washington Heights, Ann Arbor, MI 48109, USA.

Roger Lopez (R)

Sustainable Sciences Institute, Managua 14007, Nicaragua.
Laboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Ministry of Health, Managua 16064, Nicaragua.

Sergio Ojeda (S)

Sustainable Sciences Institute, Managua 14007, Nicaragua.
Centro de Salud Sócrates Flores Vivas, Ministry of Health, Managua 12014, Nicaragua.

Eduardo Azziz-Baumgartner (E)

Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.

Angel Balmaseda (A)

Sustainable Sciences Institute, Managua 14007, Nicaragua.
Laboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Ministry of Health, Managua 16064, Nicaragua.

Aubree Gordon (A)

Department of Epidemiology, School of Public Health, University of Michigan, 1415 Washington Heights, Ann Arbor, MI 48109, USA.

Classifications MeSH